M THer Innovative mobile technology to support the care of women - - PowerPoint PPT Presentation

m ther
SMART_READER_LITE
LIVE PREVIEW

M THer Innovative mobile technology to support the care of women - - PowerPoint PPT Presentation

M THer Innovative mobile technology to support the care of women with gestational diabetes mellitus Dr Mar arlie lien Var arnfie ield ld CSIRO AEHRC BIOMEDICAL HEALTH HEALTH INFORMATICS INFORMATICS SERVICES Biostatistics, imaging


slide-1
SLIDE 1

Innovative mobile technology to support the care of women with gestational diabetes mellitus

Dr Mar arlie lien Var arnfie ield ld

M♡THer

slide-2
SLIDE 2

CSIRO AEHRC

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

BIOMEDICAL INFORMATICS

Biostatistics, imaging and genomics based - clinical workflows

HEALTH INFORMATICS

Improving health system performance & productivity from electronic health data

HEALTH SERVICES

Improving access to services & management of chronic diseases

slide-3
SLIDE 3

CVD

‘Cardihab’

CKD

PD-Buddy

COPD

M-COPD

Diabetes

  • M♥THER
  • Insulin Stab

Mental health Health-e Minds

mHealth projects

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-4
SLIDE 4

GDM - What is the problem?

  • GDM is one of the most common medical complications of pregnancy
  • Usually occurs around the 24th to 28th week of pregnancy
  • Associated with short and long term risks for both mother and baby, especially if blood

glucose levels are not well controlled

  • Incidence of GDM is increasing
  • New diagnostic criteria for GDM were introduced in 2014
  • At Redland Hospital, 16% of women engaged in Maternity Services diagnosed with GDM

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-5
SLIDE 5

Challenges

Women with GDM

Midwife Obstetrician Endocrinologist Diabetes Educator Dietitian

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-6
SLIDE 6

Key problems

Suboptimal Co-ordination

  • f Care

Inconvenient Ineffective

Women with GDM carry a paper based blood glucose level diary Results not always available to the MDT team in a timely manner

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-7
SLIDE 7

Our solution

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-8
SLIDE 8

Our solution

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-9
SLIDE 9

Redland Feasibility Study (n=40)

Primary outcomes:

  • User adoption and user satisfaction

Secondary outcomes:

  • Number of BGL clinical reviews
  • Frequency of antenatal contact
  • Occasions of service related to GDM attended by women
  • Time to commencement of therapy

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-10
SLIDE 10

Study Cohort

Inclusion criteria

  • confirmed 1st OGTT diagnosis of GDM diagnosed between K24-28
  • at least 16 years of age
  • referred from general practitioner for antenatal care at Redland Hospital prior to K20
  • wning and ability to use smart mobile phone (both Androids and Apple phones)
  • ability (and willingness) to upload data either via WiFi or Mobile Data
  • ability to speak and understand English

Exclusion criteria

  • ther types of diabetes
  • ther illnesses that would limit participation e.g. chronic kidney disease (stage3-4)
  • a known history of major psychiatric illness

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-11
SLIDE 11

Recruitment

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-12
SLIDE 12

Study Outcomes

  • Survey responses from the women showed the app is user friendly, convenient, and

continuation is highly recommended

  • Treating clinicians reported improved communication with the women they treat and showed

an increase in multi-disciplinary co-ordination amongst themselves

  • BGL clinical reviews were significantly higher with the introduction of M♡THer, as was

frequency of ante-natal contact. Time to treatment and ante-natal clinic visits were comparable

  • 8 women were identified with elevated readings in the first week of using the app enabling

early intervention

  • Due to elevated fasting BGL’s 12 were commenced on Metformin, 8 were commenced on

insulin

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-13
SLIDE 13

Interest

  • Health Round Table Winner, Category: “Improving self-care”, Brisbane, July 2017
  • RN Breakfast Show interview, May 2018
  • Media report, Essentialbaby, May 2018
  • Presentation, Australian Diabetes Educators Association (ADEA) QLD State Conference, Gold

Coast, May 2018

  • 2018 iAwards Nominee, Queensland Awards, Brisbane, Jun 2018
  • Show cased at the Australasian Diabetes in Pregnancy (ADIPS) Conference, Adelaide, Aug

2018

  • Metro South Health Board Chair’s Award, Winner in Category: “Innovation Through Digital

Technology”, Brisbane, Sep 2018

  • International Hospital Federation, Gold Award Winner: “Excellence Award for Quality &

Safety and Patient Centred Care” Brisbane, Oct 2018

  • Invited presentation, Australasian Diabetes Advancements and Technology Summit. Sydney,

Nov 2018

  • Queensland Health Award of Excellence, Highly Recommended Dec 2018

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-14
SLIDE 14
  • Funded for further implementation at all

MSH Antenatal Clinics

  • Translating platform into different languages
  • Offering MoTHer to all women diagnosed

with GDM

  • FHIR enabled platform development
  • Commencing July 2019

Implementation study MSH

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-15
SLIDE 15

Real world…

Adapted from https://www.kingsfund.org.uk/projects/nhs-65/alternative-guide-new-nhs-england-2013

NDIS

GPs

PIR FD A

Marlien Varnfield, AEHRC, CSIRO

slide-16
SLIDE 16
  • Medical advances, emerging technologies, consumer choices and expectations
  • Providing high assurance security measures to put patients' privacy and security first
  • Managing digital security to reduce the risk of downtime and breaches
  • Integration with clinical systems
  • Lack of standardised terminology, system architecture, indexing and regulation
  • Change management

Implementation challenges

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO

slide-17
SLIDE 17

Acknowledgments

Principal Investigator:

Dr Wendy Dutton Divisional Director of Women’s and Children’s Services, Metro South Health (MSH)

Co-Investigators:

Dr Joel Iedema, Director of Medicine, Redland Hospital; Liesel Higgins, Redesign Manager, Transformation, Innovation, Collaborative Team, MSH Georgia Hellen, A/Project Manager Redesign, Transformation & Innovation Collaborative Planning Engagement Reform, MSH Naomi Scolari, Project Officer and Dietitian, Redland Hospital; Roisine Warwick, Diabetes Educator (Clinical nurse consultant), Redland Hospital; Janet Knowles, Nurse Unit Manager, Women and Birthing, Redland Hospital; Barbara Kleine, Senior Dietitian, Redland Hospital; Denis Morton, Chronic Disease Team Leader, Redland Hospital; Dr Rachel Stoney, Director Nutrition and Dietetics, Redland Hospital.

Dr Marlien Varnfield, AEHRC, Health & Biosecurity, CSIRO